ATE521623T1 - Neues, bei prostatakrebs exprimiertes gen und verwendungsverfahren - Google Patents

Neues, bei prostatakrebs exprimiertes gen und verwendungsverfahren

Info

Publication number
ATE521623T1
ATE521623T1 AT02795643T AT02795643T ATE521623T1 AT E521623 T1 ATE521623 T1 AT E521623T1 AT 02795643 T AT02795643 T AT 02795643T AT 02795643 T AT02795643 T AT 02795643T AT E521623 T1 ATE521623 T1 AT E521623T1
Authority
AT
Austria
Prior art keywords
ngep
disclosed
prostate cancer
gene expressed
polynucleotides
Prior art date
Application number
AT02795643T
Other languages
English (en)
Inventor
Ira Pastan
Tapan Bera
Curt Wolfgang
Byungkook Lee
James Vincent
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE521623T1 publication Critical patent/ATE521623T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02795643T 2001-11-14 2002-11-13 Neues, bei prostatakrebs exprimiertes gen und verwendungsverfahren ATE521623T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33630801P 2001-11-14 2001-11-14
PCT/US2002/036648 WO2003042370A2 (en) 2001-11-14 2002-11-13 New gene expressed in prostate cancer and methods of use

Publications (1)

Publication Number Publication Date
ATE521623T1 true ATE521623T1 (de) 2011-09-15

Family

ID=23315502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795643T ATE521623T1 (de) 2001-11-14 2002-11-13 Neues, bei prostatakrebs exprimiertes gen und verwendungsverfahren

Country Status (5)

Country Link
US (2) US7816087B2 (de)
EP (1) EP1497320B1 (de)
AT (1) ATE521623T1 (de)
AU (1) AU2002360392A1 (de)
WO (1) WO2003042370A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360392A1 (en) * 2001-11-14 2003-05-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of New gene expressed in prostate cancer and methods of use
WO2004092213A1 (en) * 2003-04-08 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Healthand Human Services Gene expressed in prostate cancer, methods and use thereof
WO2010123813A1 (en) 2009-04-20 2010-10-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogenic epitopes of ngep antigen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
EP0671926B1 (de) 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunmodulierende peptide
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US6165460A (en) 1995-07-10 2000-12-26 Therion Biologics Corporation Generation of immune responses to prostate-specific antigen (PSA)
US6268170B1 (en) * 1995-11-14 2001-07-31 Northwestern University α-Tocopherol transport protein: compositions and methods
DE60044350D1 (de) 1999-03-26 2010-06-17 Jackson H M Found Military Med Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2002360392A1 (en) * 2001-11-14 2003-05-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of New gene expressed in prostate cancer and methods of use

Also Published As

Publication number Publication date
AU2002360392A1 (en) 2003-05-26
US7897355B2 (en) 2011-03-01
US20040241702A1 (en) 2004-12-02
EP1497320B1 (de) 2011-08-24
WO2003042370A3 (en) 2004-11-04
EP1497320A4 (de) 2005-06-22
US7816087B2 (en) 2010-10-19
WO2003042370A2 (en) 2003-05-22
US20090202552A1 (en) 2009-08-13
EP1497320A2 (de) 2005-01-19
AU2002360392A8 (en) 2003-05-26

Similar Documents

Publication Publication Date Title
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
IL171356A (en) Anti-interferon receptor antibody for treatment of inflammatory bowel disease
NO20082559L (no) Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer
EP1499885A4 (de) Neue fusionsproteine und molekulare bindungsassays
BR0315161A (pt) Anticorpo isolado, polinicleotìdeo isolado, vetor, célula hospedeira, método de produzir um anticorpo, e, composição
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
WO2005120166A3 (en) Antibodies for selective apoptosis of cells
EP1708745A4 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
ATE372784T1 (de) Rekombinante proteine, die epitope des humanen papillomavirus inseriert in einem adenylatecyclase protein oder in dessen fragmenten tragen, und deren terapeutischen verwendung.
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
WO2004024750A3 (en) Cd44-binding ligands
EP1090294A4 (de) Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-gens und peptiden, die von ssx oder ny-eso-1 abgeleitet sind
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
ATE521623T1 (de) Neues, bei prostatakrebs exprimiertes gen und verwendungsverfahren
DE602004029394D1 (de) Antikörper variable region eines monoklonalen antikörpers gegen den humanen tumor nekrose faktor-alpha und dafür kodierendes gen
ATE493431T1 (de) An der oberfläche befindliche campylobacter jejuni-polypeptide
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE60130804D1 (de) Antagonistischer antikörper gegen pro842
DE60117788D1 (de) Menschliche wingless-änhliche gene
AU2003261102A1 (en) Novel polynucleotide and polypeptide sequences and uses thereof
BR0214288A (pt) Anticorpos monoclonais especìficos para tumor, ácidos nucléicos que codificam tais anticorpos e método para redução de proliferação de células neoplásicas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties